Indicators: | Insulin levels at 0, 30 and 120 min after an oral glucose tolerance test (OGTT). | ||||||||
---|---|---|---|---|---|---|---|---|---|
Covariates in all models: | Glucose and C-peptide levels at 0, 30 and 120 min after OGTT. | ||||||||
Stage 1 | Stage 2 | Final model | |||||||
Women | |||||||||
Number of classes | 17 | 18 | 19 | 18 | 18 | 18 | 18 | 18 | 19 |
Additional covariates | BMI | WH | TG | HDLC | Chol. | BCagec | |||
df a | 551 | 583 | 615 | 746 | 746 | 746 | 746 | 746 | 1,188 |
AIC | 85,626 | 81,531 | 8,.472 | 8,.330 | 81,487 | 81,473 | 81,411 | 81,490 | 80,962 |
BIC | 86,322 | 82,870 | 8,.886 | 82,769 | 82,925 | 82,911 | 82,849 | 82,928 | 82,694 |
Sample-Size Adjusted BIC | 85,947 | 82,148 | 8,.124 | 81,994 | 82,150 | 82,136 | 82,074 | 82,152 | 81,759 |
Entropy | 0.876 | 0.868 | 0.859 | 0.872 | 0.862 | 0.873 | 0.872 | 0.871 | 0.879 |
Chi-tests:b | |||||||||
AIC | <E-5 | <E-5 | <E-5 | <3*E-4 | <E-5 | <E-5 | <6*E-4 | <E-5 | |
BIC | <E-5 | - | <E-5 | - | - | <0.24 | - | <0.33 | |
BICadj | <E-5 | <0.027 | <E-5 | - | <0.75 | <E-5 | - | <E-5 | |
Men | |||||||||
df | 551 | 583 | 615 | 746 | 746 | 746 | 746 | 746 | 1,188 |
AIC | 83,973 | 83,840 | 83,792 | 83,643 | 83,792 | 83,726 | 83,688 | 83,722 | 83,226 |
BIC | 85,237 | 85,181 | 85,210 | 85,084 | 85,233 | 85,166 | 85,129 | 85,162 | 84,962 |
Sample-Size Adjusted BIC | 84,556 | 84,459 | 84,447 | 84,309 | 84,457 | 84,391 | 84,354 | 84,387 | 84,028 |
Entropy | 0.886 | 0.883 | 0.882 | 0.888 | 0.881 | 0.881 | 0.884 | 0.884 | 0.898 |
Chi-tests: | |||||||||
AIC | <E-5 | <E-5 | <E-5 | <E-5 | <E-5 | <E-5 | <E-5 | <E-5 | |
BIC | <E-5 | - | <E-5 | - | <0.65 | <E-5 | <0.37 | <0.39 | |
BICadj | <E-5 | <0.51 | <E-5 | 1.00 | <E-5 | <E-5 | <E-5 | <E-5 |